Search results
Kingsway Announces Fireside Chat With Will Thorndike at Its Investor Day at the New York Stock...
Digital Journal· 6 days agoGRC Application Deverra Therapeutics Granted FDA Fast Track Designation for DVX101 (Dilanubicel) for the Treatment of Acute Myeloid & ...
Essense of Australia Celebrates 'That First Look' in New Collection
Digital Journal· 6 days agoGRC Application Deverra Therapeutics Granted FDA Fast Track Designation for DVX101 (Dilanubicel) for the Treatment of Acute Myeloid & ...
InfusionPoints Announces the Beta Launch of Command Center for U.S. Government, a Purpose-Built GRC...
Digital Journal· 6 days agoMore from ACCESSWIRE Deverra Therapeutics Granted FDA Fast Track Designation for DVX101 (Dilanubicel) for the Treatment of Acute Myeloid
Kura Oncology, Inc. (NASDAQ:KURA) Stock Holdings Lessened by Mirae Asset Global Investments Co. Ltd.
ETF DAILY NEWS· 5 days agoMirae Asset Global Investments Co. Ltd. lessened its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
Critical Survey: Coeptis Therapeutics (COEP) versus The Competition
ETF DAILY NEWS· 6 days agoCoeptis Therapeutics (NASDAQ:COEP – Get Free Report) is one of 289 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We ...
BioLineRx (NASDAQ:BLRX) Upgraded by StockNews.com to Sell
ETF DAILY NEWS· 7 days agoStockNews.com upgraded shares of BioLineRx (NASDAQ:BLRX – Free Report) to a sell rating in a research note published on Tuesday morning. Separately, HC Wainwright restated a buy rating and issued ...
Cullinan Oncology, Inc. (NASDAQ:CGEM) Sees Large Growth in Short Interest
ETF DAILY NEWS· 2 days agoCullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 1,680,000 shares ...
ImmunityBio Inc. Drug Approved By FDA
The Post-Journal· 5 days agoOn Monday, the Food and Drug Administration officially approved ANKTIVA, a treatment for unresponsive non-muscle invasive bladder cancer. “The FDA’s...
Biophytis Announces Transfer of ADSs to OTC Market
Digital Journal· 6 days agoGRC Application Deverra Therapeutics Granted FDA Fast Track Designation for DVX101 (Dilanubicel) for the Treatment of Acute Myeloid & ...
Affimed (NASDAQ:AFMD) Short Interest Update
ETF DAILY NEWS· 2 days agoAffimed (NASDAQ:AFMD – Get Free Report) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 219,400 shares, an increase ...
